Objective-The H2.0-like homeobox transcription factor (HLX) plays an essential role in visceral organogenesis in mice and has been shown to regulate angiogenic sprouting in vitro and in zebrafish embryos. We therefore examined the role of HLX in vascular development in mouse and avian embryos. Approach and Results-In situ hybridization showed that Hlx is expressed in a subset of sprouting blood vessels in postnatal mouse retinas and embryos. Hlx expression was conserved in quail embryos and upregulated in blood vessels at the onset of circulation. In vitro assays showed that Hlx is dynamically regulated by growth factors and shear stress alterations. Proangiogenic vascular endothelial growth factor induces Hlx expression in cultured endothelial cells, whereas signals that induce stalk cell identity lead to a reduction in Hlx expression. HLX was also downregulated in embryos in which flow was ablated, whereas injection of a starch solution, which increases blood viscosity and therefore shear stress, causes an upregulation in HLX. HLX knockdown in vitro resulted in a reduction in tip cell marker expression and in reduced angiogenic sprouting, but Hlx −/− embryos showed no defect in vascular sprouting at E8.5, E9.5, or E11.5 in vivo. Vascular remodeling of the capillary plexus was altered in Hlx −/− embryos, with a modestly enlarged venous plexus and reduction of the arterial plexus. Conclusions-Our findings indicate not only that Hlx regulates sprouting in vitro, but that its role in sprouting is nonessential in vivo. We find HLX is regulated by shear stress and a subtle defect in vascular remodeling is present in knockout embryos. (Arterioscler Thromb Vasc
H omeobox genes are evolutionary conserved genes that are chromosomally clustered in many animal genomes. 1 Homeobox genes encode transcription factors with a conserved 60-amino acid DNA-binding homeodomain and are involved in transcriptional regulation of eukaryotic developmental processes, particularly in directing tissue morphogenesis and patterning. 2 The H2.0-like homeobox transcription factor (HLX) is a diverged, nonclustered homeodomain protein, with a pivotal role in visceral organogenesis and enteric nervous system development. [3] [4] [5] [6] In mouse embryos, the highest expression of Hlx is detected in the mesenchyme of the developing liver and intestine. 4, 6 HLX is highly conserved in its gene structure, expression pattern, and protein sequence in 9 different species, ranging from fish to avians and mammals, 7 which implies an important evolutionary function. Indeed, deletion of the gene encoding Hlx in mice results in embryonic lethality at E15, with intestines that fail to elongate and expand likely because of defects in guidance cues in the enteric nervous system. 3, 6 In addition to defects in intestinal growth, Hlx −/− embryos exhibit severe anemia and hypoplasia of the liver (3% of its normal size). 4 These findings demonstrate important developmental functions of HLX during visceral mesoderm growth.
HLX is also implicated in human pathology: HLX is overexpressed in patients with acute myeloid leukemia, which induces formation of aberrant progenitor cells with unlimited clonogenicity and blocked differentiation. Inhibition of HLX in leukemic cells reduces proliferation and clonogenicity, identifying HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in acute myeloid leukemia. 8, 9 In endothelial cells cultured in vitro, overexpression of HLX was shown to inhibit endothelial cell sprouting, migration, and vessel formation, without affecting proliferation.
HLX was shown to robustly upregulate expression of repulsive cell-guidance proteins, such as uncoordinated 5 homolog B (UNC5B), plexin-A1, and semaphorin-3G. 10 It was proposed in this context that HLX may function to balance attractive guidance cues (when stimulated by vascular endothelial growth factor [VEGF] ) with repulsive vessel guidance cues to regulate sprouting in endothelial cells. 10 In addition, in zebrafish, hlx expression is confined to endothelial cells sprouting from the dorsal aorta into the intersegmental region and not expressed in adjacent nonangiogenic endothelial cells. Morpholino-mediated knockdown of Hlx led to stunted intersegmental vessel sprouts which failed to connect with neighboring vessels; thus, Hlx was proposed to promote/reinforce stalk cell potential in this context. 11 These findings showed that both loss and gain of function of HLX affected vessel sprouting, suggesting important roles of this transcription factor in vessel branching morphogenesis. However, previous studies using genetic loss-of-function models in mice have not addressed the role of HLX in blood vessel formation.
Here, we show that endothelial cells express Hlx during development in 2 amniote models: mouse and quail embryos. The expression is not ubiquitous but labels a subset of endothelial cells. We then investigate the function of HLX in angiogenic sprouting. We find that HLX controls the expression of some stalk/tip cell genes and that knockdown of Hlx inhibits sprouting in vitro. From our time course in early vascular development, we had observed that HLX expression was strongest in endothelial cells just after the onset of flow. We therefore use 3 different models to alter flow and look at HLX regulation in response to flow. We find that shear stress can upregulate HLX. We investigated whether a vascular phenotype was present in Hlx-null embryos. We find that the intraembryonic vasculature forms normally and that sprouting is normal in all tissues investigated at E8.5, E9.5, and E11.5. When we looked at the yolk sac vascular plexus, we found a remodeling defect: the venous plexus is enlarged and the vitelline vein is enlarged, as compared with control. A proportional decrease in arterial diameter is present. Our results show that although HLX can regulate sprouting in vitro, its role in vascular sprouting is nonessential in mouse embryos in vivo. In contrast, we find that HLX is upregulated by flow. We also find that Hlx ablation affects vascular remodeling.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Hlx Is Dynamically Regulated in Developing Blood Vessels in Mice and Quail Embryos
Hlx was previously described as a gene upregulated by VEGF and suppressed by Notch signaling in endothelial cells in vitro and in zebrafish embryos. 10, 11 Consistent with these results, we found that compared with wild-type controls, Hlx expression was increased (3.5-fold) in microarrays from delta-like 4 heterozygote (Dll4 +/− ) retinal endothelial cells, which present an excessive sprouting phenotype. 12 Furthermore, in situ hybridization with an Hlx antisense riboprobe on postnatal day 5 mouse retinas showed Hlx expression in a subset of tip cells, confirming the microarray results and suggesting a possible function for Hlx in sprouting angiogenesis ( Figure 1A and 1B, red and blue arrowheads).
Examination of Hlx expression in E10.5 mouse embryos revealed strongly labeled splanchnopleural visceral mesoderm associated with the developing lung and liver, whereas sense probes showed no specific signal ( Figure 1C and 1D) . Hlx expression was absent in the heart, as well as in the endothelium of the larger vascular structures such as the cardinal vein and the dorsal aorta ( Figure 1E ). Hlx expression was present in vessels branching off the aorta ( Figure 1E , black arrowhead) and in the perineural vascular plexus ( Figure 1F , arrows). Within the neural epithelium, we failed to detect any Hlx staining of endothelial cells ( Figure 1G and 1H, green arrowheads). In E12.5 embryos, Hlx expression became downregulated in the liver but remained enriched in splanchnic mesoderm and was also found in the developing sclerotome and neural tube, with strongest expression in the roof plate (data not shown). A subset of smaller blood vessels remained positive for Hlx expression in the perineural vascular plexus surrounding the neural epithelium and in the dermis. Capillaries inside the neural epithelium, however, did not stain positive for Hlx expression at E10.5 or E12.5. Together, these expression studies confirm previous reports demonstrating preferential Hlx expression in developing visceral mesoderm of mouse embryos 3, 4, 6, 7, 13 and show that a subset of sprouting vessels in the mouse retina and in the embryo, respectively, express Hlx.
To assess Hlx expression in another developing amniotic model, we performed whole-mount in situ analysis on developing quail embryos. Consistent with our findings in mice, we found Hlx to be enriched in the splanchnic mesoderm before and during formation of the intestine and liver (Figure 2A and 2B). In addition to the splanchnic mesoderm, Hlx is also detected in the branchial arches but not in the heart (Figure 2A and 2B, arrowheads). In the embryo proper, Hlx expression was absent in endothelial cells lining the heart and the dorsal aorta, consistent with previous reports. 7 We noticed a significant level of Hlx expression in the capillary plexus of the yolk sac. We chose 3 specific stages (8, 14 , and 20 somites) at which to look at vascular expression. Vascular development begins in the extraembryonic capillary plexus at 0 to 5 somites in quail embryos, when blood islands establish the primary components and set the outline of the blood vessel network. Once the initial plexus is formed de novo, the heart begins to beat and the plexus undergoes vascular remodeling. Erythroblasts enter the circulation between 11 and 13 somites. The first morphologically distinct arteries and veins are present by ≈20 somites (midvascular remodeling stage), and the mature architecture of the vascular network is attained at 4 days, or Hamburger Hamilton stage 23.
In the quail extraembryonic region, we detected Hlx in mesodermal and endothelial cells of the capillary plexus at 
HLX Regulates Endothelial Sprouting In Vitro
To examine HLX regulation and function in sprouting angiogenesis, we tested Hlx expression levels in human umbilical vein endothelial cells stimulated with VEGF or soluble DLL4 (sDLL4) and bone morphogenetic protein 9 (BMP9), which promote tip and stalk cell fate, respectively. A 24-hour stimulation of VEGF induced an 8-fold increase in the expression of Hlx ( Figure 3A) , whereas sDLL4 and BMP9 both led to a reduction in Hlx expression ( Figure 3B ). We then asked whether Hlx loss-of-function affects downstream expression of tip and stalk cell genes. Small interfering RNA-mediated knockdown of Hlx ( Figure 3C , 75% knockdown efficiency) reduced expression of some tip cell-enriched genes including endothelial specific molecule 1 (Esm1) and Dll4, but expression of Unc5B, Nidogen-2 (Nid2), Apelin, angiopoietin-2 (Ang2), plateletderived growth factor-B (PDGFB), and urokinase receptor (uPAR) was not affected by Hlx knockdown ( Figure 3D ). Furthermore, Hlx knockdown failed to increase expression of stalk cell genes Ets1, Tie2, and Jagged 1 ( Figure 3E ). These data suggest that Hlx affects expression of some, but not all, tip cell genes. To further investigate the role of HLX in sprouting angiogenesis, we used an in vitro sprouting assay with human umbilical vein endothelial cells embedded in 3-dimensional fibrin gels. 14 Small interfering RNA-mediated knockdown of
Hlx significantly reduced VEGF-induced endothelial sprouting ( Figure 3F ). Taken together, these results suggest that while HLX regulates the expression of only a few tip cell genes, it can still influence sprouting angiogenesis in vitro.
HLX Expression Is Regulated by Flow and Shear Stress Levels In Vivo and In Vitro
Given that we saw a significant increase in HLX expression in endothelial cells at the onset of circulation, we next investigated whether blood flow regulated HLX expression. To test this, we performed loss-of-flow and gain-of-flow experiments in quail embryos. For loss of flow, we ablated flow by snipping the inlet to the heart at 8 somites and allowed the embryo to develop until 18 somites, which results in embryos with no cardiac output and arrested vascular remodeling. 15 The expression of HLX in the absence of flow was then determined by Western blot analysis of whole embryo lysates. We found that HLX expression is significantly decreased in embryos lacking blood flow when compared with stagematched controls ( Figure 4A ).
Blood flow creates a mechanical force on endothelial cells called shear stress, which is a function of fluid viscosity, flow rate, and vessel diameter. Thus, by increasing the viscosity of blood, one can increase the shear stress in the circulation (n=8; A) , whereas stimulation with bone morphogenetic protein 9 (BMP9) and delta-like 4 (DLL4) significantly decreased Hlx mRNA levels (n=3; B). Using small interfering RNA (siRNA) against Hlx, we achieve a 75% knockdown (n=5; C). Two of 8 tip cell markers were significantly downregulated by knockdown of Hlx (n=3-5; D) . Of the 3 stalk cell markers investigated, only jagged1 expression was increased, albeit not significantly (n=3; E). Knockdown of Hlx also caused a 50% reduction in the ability of endothelial cells to form tubes in fibrin gel (n=3; F). All values are mean±SEM. *P<0.05; **P<0.01; ***P<0.001; 2-tailed Student t test. Bar, 100 μm (F).
without affecting flow velocity. Therefore, for the gain-of-flow experiments, we increased shear stress levels in the circulation of embryos by microinjecting a viscous starch solution at the 14-somite stage, using a method we previously developed. 16 HLX protein expression was analyzed 6 hours postinjection and found to be significantly increased in embryos with increased shear stress ( Figure 4B ). Densitometric analysis confirms significant upregulation of HLX in embryos in the vascular system in which we altered blood viscosity. These data suggest that HLX expression is not only endogenously upregulated at the onset of blood circulation, but also affected by manipulating patterns of flow in the embryo.
We further investigated the possibility that changes in shear stress can affect Hlx expression in an in vitro system. We exposed cultured human abdominal aortic endothelial cells to flow using a parallel plate flow chamber. Human abdominal aortic endothelial cells were seeded on a microscope slide, placed in a parallel plate flow chamber, and exposed to low levels of laminar flow (5 dyn/cm 2 ) for 1 hour. These levels are similar to the level of shear stress present at the onset of circulation. 17 Our data show that in cultured endothelial cells, Hlx RNA expression is significantly upregulated by steady embryonic-like flow compared with control static conditions ( Figure 4C ). Western blot confirms that HLX protein expression is upregulated in endothelial cells stimulated with embryonic laminar flow for 6 hours ( Figure 4C ).
Hlx
−/− Embryos Show Normal Angiogenic Sprouting But Defective Yolk Sac Vascular Remodeling
To determine whether HLX function was required for angiogenic sprouting and yolk sac vascular remodeling in vivo, we next examined vascular development in Hlx −/− mouse embryos. 4 Intraembryonic vascular development seemed to occur normally in these embryos. At E8.5, the dorsal aorta and heart had formed normally ( Figure 5A ). At E9.5, intersomitic vessels sprout from the dorsal aorta and fuse to form the dorsal vein. No difference was observed between control or knockout embryos ( Figure 5B) . Formation of the branchial arch arteries was also phenotypically normal as was cranial vascularization. Staining for endomucin also did not reveal any differences in the vasculature of the embryo at E9.5 between heterozygous and knockout littermates ( Figure 5C ).
Though intraembryonic sprouting angiogenesis was normal, we next looked at vascular remodeling in the yolk sac of Hlx-null embryos. The yolk sac capillary plexus forms as an immature plexus that undergoes remodeling between E8.5 and E9.5. We found no defects in the capillary plexus of Hlx −/− embryos at E8.5, before the onset of flow (data not shown). At E9.5, Hlx −/− yolk sacs had undergone vascular remodeling and were not grossly affected by ablation of Hlx as compared with control ( Figure 5D ). However, closer inspection of the remodeled E9.5 vascular plexus showed defects in the conformation of the arterial and venous plexus. To quantify the morphological differences in the Hlx +/− and Hlx −/− vascular plexus, we measured lumen diameter of the veins and arteries, the surface area with arterial versus venous morphology, the alignment of arterial endothelial cells with the direction of blood flow, the endothelial cell shape index, and the density of branch points in the arterial and venous plexus. Among these morphometric measurements, the surface area of the Hlx −/− venous plexus and the diameter of the vitelline vein and artery were significantly different when compared with controls. Specifically, the venous plexus occupies a larger percentage of the vascularized yolk sac than in wild-type embryos ( Figure 5D and 5E). The vitelline artery tree is reduced in size, and the vitelline vein is increased in diameter ( Figure 5E ). In addition, we investigated arterial-venous identity and found normal expression of connexin40, an arterial-specific marker, in the Hlx −/− vascular plexus ( Figure 5F ), suggesting that induction of arterial gene expression is unaffected. For the loss-of-function experiments, flow was ablated at 8 somites in quail embryos and HLX protein levels were assessed at 18 somites. HLX expression is downregulated when blood flow is ablated, as compared with age-matched controls (A; n=3, 3-6 embryos per sample). Protein loading was assessed by Coomassie staining (bottom). For the gain-of-function experiments, quail embryos were injected with a starch solution at 14 somites and HLX protein levels were assessed at 22 somites. HLX is upregulated when blood viscosity is increased compared with age-matched controls (B; n=3 with 3-6 embryos per sample). Western blot analysis of human endothelial cells exposed to laminar flow for 6 hours (5 dyn/cm 2 ) confirms that HLX protein expression is upregulated by shear stress (n=3; C). Hlx RNA levels were also increased by simulating human abdominal aortic endothelial cells with laminar flow for 1 hour (n=6). All values are mean±SEM. *P<0.05; ***P<0.001; 2-tailed Student t test.
We next evaluated Hlx-deficient embryos at E11.5 through hematoxylin and eosin staining on sections. As previously reported, 4 we found that the liver completely failed to form in Hlx-null embryos ( Figure 6A and 6B, arrow) . Though the intestine formed, its development was significantly retarded (Figure 6A and 6B) .
Examination of vascular development at this stage by CD31 staining of transverse sections through the embryo showed no ; E). The diameter of the vitelline artery and vein was also significantly different between Hlx +/− and Hlx −/− embryos (E). Staining for connexin40 (Cx40) showed that arterial differentiation was normal (F). Bars, 1000 μm (A, B, and D) , 200 μm (C), and 300 μm (F). All values are mean±SEM. *P<0.05; **P<0.01; 2-tailed Student t test. defect in the dorsal aorta or its branches ( Figure 6C ). Smooth muscle cells were present around the dorsal aorta, and no differences were observed in the thickness of the smooth muscle cell layer ( Figure 6D ). On longitudinal sections through the embryo, both intersomitic arteries and veins appeared normal ( Figure 6E ). The embryonic hindbrain is vascularized by angiogenic sprouting between E10.5 and E11.5, therefore we measured vascular density at E11.5 in Hlx +/+ and Hlx −/− hindbrain whole mounts ( Figure 6F ). Quantification of branch point density showed no difference between wild-type and Hlx −/− embryos. Therefore, the remodeling defect that occurred in the yolk sac at E9.5 did not lead to detectable intraembryonic vascular defects by E11.5, suggesting that HLX modulates vessel remodeling but is dispensable for angiogenic sprouting in mice.
Discussion
In zebrafish embryos, hlx expression has been shown to be dynamically regulated during sprouting angiogenesis, with initial tip cell selective expression that subsequently becomes restricted to stalk cells and is absent from other embryonic endothelial cells. 11 We show here that Hlx is also expressed in subsets of sprouting vessels in mouse embryos in vivo, including tip cells in the developing retina. We had previously performed microarray comparison between wild-type and Dll4 +/− retinal endothelial cells and found Hlx to be upregulated in the Dll4 +/− population. Furthermore, we show that in cultured human endothelial cells, Notch activation by DLL4 decreases Hlx expression, whereas VEGF increases it, as reported previously. 10 These data, together with other reports, 10, 11 show that Hlx regulation by VEGF and Notch signaling is conserved among zebrafish, mouse, and human endothelial cells. Overexpression of HLX in cultured endothelial cells had previously been shown to inhibit angiogenic sprouting through upregulation of guidance receptors including the repulsive netrin receptor UNC5B. 10, 18 Here, we show that knockdown of Hlx also inhibits endothelial sprouting in vitro, indicating that both loss and gain of HLX function affect in vitro sprouting. In line with these observations, hlx knockdown in zebrafish embryos led to decreased intersomitic vessel formation, indicating functional requirement of HLX for angiogenic sprouting in this species in vivo. 11 In contrast, we show here that sprouting angiogenesis occurs normally in mouse embryos deficient for Hlx. Hlx −/− embryos die during midgestation because of severe anemia attributable to defective liver development. 4 Analysis of vessel development in embryos between E8.5 and E11.5 failed to reveal any obvious defects in formation of major vessels such as the dorsal aorta and cardinal vein or their side branches. Thus, in contrast to the in vitro setting and zebrafish in vivo data, 10, 11 loss of Hlx in the mouse embryo does not affect sprouting angiogenesis. This is in agreement with the in situ hybridization results, which show that Hlx is expressed in only a subset of sprouting vessels. Furthermore, our in vitro experiments show that most tip and stalk cell genes are unaffected by Hlx knockdown. Therefore, we have been unable to confirm a role for HLX in sprouting angiogenesis in the mouse embryo. Although we cannot exclude the possibility that minor phenotypes may have been missed, our results indicate that HLX is dispensable for sprouting in mouse embryos. Inducible, endothelial-specific Hlx knockout may reveal a role for HLX in sprouting in other tissue beds and at later stages of development or in pathology.
In addition to expression in tip cells and sprouting vessels, we found that endothelial-specific HLX expression was increased at the onset of circulation. We confirmed that blood flow and more specifically shear stress was responsible for the increase in HLX expression using 3 different models: (1) by ablating flow in the embryo, (2) by increasing shear stress in the embryonic circulation, and (3) by exposing human endothelial cells to shear stress in vitro. All 3 models confirmed that HLX is upregulated in response to steady laminar-type flow. In vivo, we observed a yolk sac remodeling defect after the onset of extraembryonic blood flow, suggesting that blood flow is a physiological signal for HLX regulation and that HLX is required for vessel remodeling. The defect in remodeling may be a direct cause of the defective shear-induced signaling pathways, but this remains to be definitively proven. In the intestine, expression of HLX by mesenchymal cells has been shown to direct neural crest cell migration. 3 Given that we observe Hlx expression in mesodermal cells of the yolk sac, we cannot exclude the possibility that factors expressed by nonendothelial cells are driving the remodeling phenotype. Although the relative balance of arteries and veins is altered in the knockout embryos, it is important to note that expression of arterial-specific gene is unaffected in the Hlx −/− vascular plexus, as shown by connexin40 staining. Signals from shear stress are transduced through VEGF receptor 2, 19 suggesting that HLX may be induced downstream of VEGF receptor 2 signaling in both angiogenic sprouts and perfused embryonic blood vessels. Whether shear-induced expression of HLX has an effect on angiogenic sprouting, however, is unclear.
Using adenoviral constructs to upregulate recombinant HLX, Testori et al 10 showed that HLX expression induces an upregulation of Notch targets including UNC5B, plexin-A1, semaphorin-3G, and hairy and enhancer of split 1 (HES1). UNC5B, 20 semaphorin-3G, 21 and HES1 22 all display arterialspecific expression patterns. Interestingly, the endothelialspecific double mutant of Hes1/Hes5 shows a comparable phenotype to the Hlx −/− mutants. 22 The double mutants exhibit a defect in vascular remodeling such that the diameter of vessels branching off the main carotid artery is decreased, but no change in the diameter of the major arteries themselves is observed. The authors did not investigate the venous vasculature. Given that Hlx ablation results in a similar phenotype to Hes1/5 ablation, we propose that HLX is upstream of HES1 in the process of vascular remodeling.
The promoter of Hlx shows a significant number of shear-response elements previously shown to regulate shear response in gene promoters. In silico analysis of the aligned mouse and human Hlx promoters revealed the presence of 28 different transcription factor-binding sites and cis-acting elements conserved on the promoter, which have been previously shown to regulate shear response in other gene promoters. It is important to note that the transcriptional responsiveness to shear stress is determined by a combination of shear-response elements rather than by a single shear-response element. Most notably, 2 inverted CCAAT motifs are found in the Hlx promoter, which were previously identified to be functionally important for Hlx expression. 23 The CCAAT motif binds CCAAT-enhancer-binding proteins and has been identified as a positive and robust shear-response element. 24 Furthermore, two Krüppel-like factor 2-binding sites (2 CACCC boxes, located within 50 base pairs of start site) are located proximal to the mouse and human Hlx start site. Expression of Krüppel-like factor 2 regulates many shear-expressed genes. 25, 26 Given the conserved presence of multiple shear stress-response elements on the mouse and human Hlx promoters, including the well-characterized Krüppel-like factor 2, we propose that HLX is upregulated in response to shear stress by shear-sensitive transcription factors and that it is a downstream effector of mechanotransduction rather than a primary transcription factor required for mechanosensitive gene induction.
Although our finding shows that HLX is required for normal yolk sac vascular remodeling at E9.5, this defect does not lead to apparent major intraembryonic vessel remodeling defects at E11.5. We did not pursue analysis of potential flow-induced phenotypes later in development because flowinduced defects cannot be differentiated from defects in hematopoiesis seen in Hlx −/− embryos. Primitive hematopoiesis, which begins in the yolk sac at E7.5, migrates to the embryonic liver at E10.5, where the secondary site of hematopoiesis takes place. The Hlx-null embryos fail to form a liver and are anemic by E13.5, 4 inevitably resulting in a decreased hematocrit attributable to reduced hematopoietic cell population. Shear stress is a function of not only the rate of blood flow but also the viscosity of the blood. The hematocrit is the primary determinant of blood viscosity. As such, as the Hlx −/− embryos become anemic by E13.5, the shear stress levels also decrease. To study the effects of HLX on flow-induced remodeling in the vasculature independently of liver defects, an endothelialspecific deletion of Hlx would be necessary.
Taken together, our results show that Hlx expression is conserved in a subset of developing blood vessels in mouse and avian embryos and indicate that its expression in developing blood vessels is dynamically regulated. Our in vitro results show that HLX expression can be controlled both by signals for sprouting and by shear stress. Our in vivo results show that the role of HLX in sprouting is nonessential. Hlx-null embryos do show a defect in vascular remodeling in which patterning is abnormal.
